文献速递呼吸道感染

RSV 通过上调 SIGLEC1 抑制巨噬细胞自噬并促进炎性介质分泌

Respiratory syncytial virus-induced SIGLEC1 upregulation inhibits macrophage autophagy and facilitates inflammatory mediator secretion
RSS 订阅 · BMJ Open Respiratory Research

该研究以 THP-1 来源巨噬细胞为对象,用荧光显微镜监测 RSV 感染,并以 CCK-8 测活力、RT-qPCR 与蛋白印迹(WB)测 SIGLEC1 表达。结果显示 RSV 感染后巨噬细胞活性受抑、SIGLEC1 明显上调,自噬受抑(ATG5、LC3II 下降、自噬体形成减少)并转向 M1 表型、促炎因子分泌增加;敲低 SIGLEC1 或使用自噬激活剂可逆转上述效应。

要点

  • RSV 感染上调巨噬细胞 SIGLEC1 并抑制自噬。
  • SIGLEC1 上调推动巨噬细胞向 M1 表型极化并增加促炎因子分泌。
  • 敲低 SIGLEC1 或激活自噬可恢复自噬并减少炎性介质释放。

核心结论

  • RSV 利用 SIGLEC1 抑制巨噬细胞自噬、强化 M1 极化并增加细胞因子分泌,为靶向该病毒的治疗提供依据。

研究设计与样本

  • 以 THP-1 来源巨噬细胞为研究对象,用荧光显微镜监测 RSV 感染,CCK-8 测细胞活力,RT-qPCR 与蛋白印迹(WB)分析 SIGLEC1 表达。
  • 开展基因集富集分析以识别与 SIGLEC1 富集相关的通路,并构建 SIGLEC1 敲低巨噬细胞。
  • 用 WB、免疫荧光和单丹磺酰尸胺染色检测 RSV 感染后自噬水平,通过形态学观察、流式细胞术、ELISA 及一氧化氮合酶表达分析评估表型与炎症反应。

主要发现

  • RSV 感染后巨噬细胞活性显著受抑,SIGLEC1 表达明显上调。
  • SIGLEC1 上调有效抑制巨噬细胞自噬,表现为 ATG5 与 LC3II 水平下降、自噬体形成减少。
  • RSV 感染驱动巨噬细胞向 M1 表型极化,并伴促炎细胞因子分泌增加。
  • 敲低 SIGLEC1 或使用自噬激活剂可恢复自噬水平并抑制炎性介质释放,上述效应可逆。

临床怎么用

  • 提示 SIGLEC1 及巨噬细胞自噬可能作为 RSV 感染相关炎症干预的潜在靶点,但尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Respiratory syncytial virus (RSV) is a leading culprit behind respiratory infections in infants. As a cornerstone of the immune defence, macrophages are instrumental in warding off invading pathogens. This study examines the molecular pathways through which RSV modulates the immune functions of macrophages during infection. Methods THP-1–derived macrophages were infected with RSV, and the infection was monitored using fluorescence microscopy. The viability of infected macrophages was measured using CCK-8, and SIGLEC1 expression was analysed by RT-qPCR and western blot (WB). Gene set enrichment analysis was performed to identify pathways associated with SIGLEC1 enrichment. SIGLEC1-knockdown macrophages were developed, and autophagy levels in these cells following RSV infection were examined using WB, immunofluorescence and monodansylcadaverine staining. The influence of RSV infection on macrophage phenotype and inflammatory responses was assessed through morphological observation, flow cytometry, ELISA and nitric oxide synthase expression analysis. Results Following RSV infection, macrophage activity was significantly repressed, and SIGLEC1 expression was markedly upregulated. This upregulation of SIGLEC1 effectively suppressed the autophagy process in macrophages, as indicated by decreased levels of ATG5 and LC3II, and reduced autophagosome formation. RSV infection also drove macrophages towards the M1 phenotype, which was accompanied by increased secretion of proinflammatory cytokines. Importantly, these effects were reversible through SIGLEC1 knockdown or treatment with an autophagy activator, which restored autophagy levels and curbed the release of inflammatory mediators. Conclusion By exposing how RSV exploits SIGLEC1 to inhibit macrophage autophagy, reinforce M1 polarisation and increase cytokine secretion, this study lays vital groundwork for new treatments targeting this viral scourge.

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Respiratory syncytial virus-induced SIGLEC1 upregulation inhibits macrophage autophagy and facilitates inflammatory mediator secretion

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。